Related Topics News -

     
 Title only   |   Print 
     
神威藥業首季營業按年減少31.9%

2025-05-09T  
《業績》神威藥業去年純利8.4億人幣跌13.4% 派第一次中期股息每股36分

2025-03-28T  
國家藥監局:引導企業及研發機構等加大創新藥和高質量仿制藥研發

2025-02-20T  
第十批國家組織藥品集採開標 62種藥品採購成功

2024-12-13T  
內地第十批藥品集中採購即將開標 國採納入62種藥品

2024-12-12T  
《業績》神威藥業首九個月營業額約28.8億人幣 按年跌近17%

2024-11-08T  
《大行》華興證券降神威藥業目標價至18元 每股淨現金接近股價及維持高分紅率

2024-09-04T  
《大行》建銀國際降神威藥業目標價至11元 上半年業績遜

2024-09-04T  
《業績》神威藥業半年純利6.26億元人民幣升27.5% 派第二次中期息11分人民幣

2024-08-29T  
恆指公司:格雷厄姆投資理念或仍適用於當今港股市場

2024-07-23T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.